JCI Insight 8: e170419, 2023
We always recommend that you consult with your physician if you have any specific concerns regarding whether a product is appropriate for you
Participants were randomised (1:1:1:1) using a web-based randomisation system to either once-daily oral semaglutide (3 mg, 7 mg or 14 mg) or once-daily oral sitagliptin 100 mg
The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication
Int J Mol Sci (2019) 20(6)
We will look at how this master antioxidant functions, why traditional supplements often fall short, and how improving your internal environment can support a calmer, healthier complexion